hit counter
BioSpecifics Technologies Corp. (BSTC) Stock News Sentiment & Price - Sentifly
BSTC - Sentifly


Profile

Watchlist

Your watchlist is empty. Go add some tickers to it!



BioSpecifics Technologies Corp. (BSTC)

USA
Biotechnology
NASDAQ
BSTC Price and Sentiment
1MO
1D
Positive, Negative
Loading chart...
BSTC Latest news
PRNewsWire
Neutral
BioSpecifics Announces Completion of Acquisition by Endo Pharmaceuticals
2020-12-02 09:09

WILMINGTON, Del., Dec. 2, 2020 /PRNewswire/ -- BioSpecifics Technologies Corp. (NASDAQ: BSTC), a biopharmaceutical company that originated and continues to develop collagenase-based therapies with a first-in-class collagenase-based product marketed as XIAFLEX® in North America, today...

Newsfile Corp
Neutral
Moore Kuehn Encourages BSTC Investors to Contact Law Firm
2020-11-13 14:10

New York, New York--(Newsfile Corp. - November 13, 2020) - Moore Kuehn, PLLC, a law firm focusing in securities litigation located on Wall Street in downtown New York City, is investigating potential claims concerning whether BioSpecifics Technologies Corp. (NASDAQ: BSTC) agreement to be acquired by Endo International PLC is fair to shareholders.Under the terms of the agreement, a tender offer expiring on December 2nd was commenced by Endo International to acquire BioSpecifics Technologies for $88.50...

PRNewsWire
Neutral
Lifshitz Law Firm, P.C. Announces Investigation of BioSpecifics Technologies Corp., Cleveland BioLabs, Inc., Concho Resources Inc., CONSOL Energy Inc., CONSOL Coal Resources LP, Endurance International Group Holdings, Inc., GCI Liberty, Inc., Liberty Broa
2020-11-11 15:18

NEW YORK, Nov. 11, 2020 /PRNewswire/ -- BioSpecifics Technologies Corp. (NASDAQ: BSTC) Lifshitz Law Firm, P.C. announces investigation into possible breach of fiduciary duties in connection with the sale of BSTC to Endo International plc for $88.50 per share. If you are a BSTC investor,...

Zacks Investment Research
Positive
BioSpecifics Technologies (BSTC) Surpasses Q3 Earnings and Revenue Estimates
2020-11-09 09:45

BioSpecifics (BSTC) delivered earnings and revenue surprises of 315.79% and 106.15%, respectively, for the quarter ended September 2020. Do the numbers hold clues to what lies ahead for the stock?

PRNewsWire
Neutral
BioSpecifics Reports Third Quarter 2020 Financial and Operating Results
2020-11-09 08:00

WILMINGTON, Del., Nov. 9, 2020 /PRNewswire/ -- BioSpecifics Technologies Corp. (NASDAQ: BSTC) ("BioSpecifics" or the "Company"), a biopharmaceutical company that originated and continues to develop collagenase-based therapies with a first-in-class collagenase-based product marketed as...

PRNewsWire
Neutral
SHAREHOLDER ALERT: Rigrodsky & Long, P.A. Reminds Investors Of Investigation of BioSpecifics Technologies Corp. Buyout
2020-11-06 13:26

WILMINGTON, Del., Nov. 6, 2020 /PRNewswire/ -- Rigrodsky & Long, P.A. announces that it is investigating BioSpecifics Technologies Corp. ("BioSpecifics") (NASDAQ GS: BSTC) regarding possible breaches of fiduciary duties and other violations of law related to BioSpecifics' agreement to be...

Zacks Investment Research
Negative
Earnings Preview: BioSpecifics Technologies (BSTC) Q3 Earnings Expected to Decline
2020-11-06 12:30

BioSpecifics (BSTC) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

PRNewsWire
Neutral
SHAREHOLDER ALERT: WeissLaw LLP Investigates BioSpecifics Technologies Corp.
2020-11-03 19:41

NEW YORK, Nov. 3, 2020 /PRNewswire/ -- WeissLaw LLP is investigating possible breaches of fiduciary duty and other violations of law by the board of directors of BioSpecifics Technologies Corp. ("BSTC" or the "Company") (NASDAQ: BSTC) in connection with the proposed acquisition of the...

Business Wire
Neutral
BIOSPECIFICS INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of BioSpecifics Technologies Corp. - BSTC
2020-11-03 17:36

NEW ORLEANS--(BUSINESS WIRE)--Former Attorney General of Louisiana Charles C. Foti, Jr., Esq. and the law firm of Kahn Swick & Foti, LLC (“KSF”) are investigating the proposed sale of BioSpecifics Technologies Corp. (NasdaqGS: BSTC) to Endo International plc (NasdaqGS: ENDP). Under the terms of the proposed transaction, shareholders of BioSpecifics will receive only $88.50 in cash for each share of BioSpecifics that they own. KSF is seeking to determine whether this consideration and the pr

PRNewsWire
Neutral
SHAREHOLDER ALERT: Monteverde & Associates PC Announces an Investigation of BioSpecifics Technologies Corp. - BSTC
2020-11-02 09:13

NEW YORK, Oct. 30, 2020 /PRNewswire/ -- Juan Monteverde, founder and managing partner at Monteverde & Associates PC, a national securities firm headquartered at the Empire State Building in New York City, is investigating BioSpecifics Technologies Corp. ("BioSpecifics" or the "Company")...

Loading more news...